BNR - CIK 0001792267
No parsed quarterly data available for Burning Rock Biotech Ltd yet.
Burning Rock Biotech Ltd reported annual revenue of $77.16M for fiscal year 2025. That is up 9.2% from $70.67M in fiscal 2024. Over the 6 fiscal years shown, annual revenue grew from $65.89M (FY 2020) to $77.16M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.